The metallothionein II gene, whose structure is highly conserved throughout the animal kingdom, is composed of three exons and two introns. Synthetic antisense oligonucleotides (ODN), with sequence complementary to the messenger RNA coding for human metallothionein II, were prepared and tested for their ability to inhibit both constitutive- and cadmium-induced metallothionein protein synthesis in human Chang liver cells and hamster lung V79 cells in culture. The property of sense ODN was also examined as a measure of sequence specificity. The antisense inhibition of metallothionein protein synthesis rendered all cell lines more susceptible to the toxic effects of cadmium. However, the sense ODN had no effects on either metallothionein protein synthesis or sensitivity to cadmium. Phosphorothioate oligonucleotides were more potent in enhancing the toxicity of cadmium than phosphodiester oligonucleotides. The antisense oligonucleotides targeted to the splice donor region between exon 1 and intron 1 was significantly more effective as an inhibitor than those targeted to either the 5'' end of the rnRNA or within exon 3. Therefore, not all antisense oligonucleotide sequences are equally efficient as inhibitors of metallothionein synthesis. Therefore, the delineation of an obvious mechanism for predicting the most potent sequence is not apparent at this time. The results of this study are interpreted to indicate that (a) metallothionein is endowed with an essential gene, (b) modifications in oligonucleotide structures show specificity in inhibiting metallothionein synthesis, and (c) antisense inhibition of metallothionein gene expression may provide a useful tool in studying the action and perhaps the function(s) of metallothionein.

Keywords:
Metallothionein, Antisense oligonucleotide, Phosphorothioate oligonucleotide, Chang liver cells, human, Lung V79 cells, hamster
This content is only available via PDF.
© 1992 S. Karger AG, Basel
1993
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.